Indeed, PAEs would promote the growth of PC3 and 22RV1 prostate cancer cells via up-regulation of MAPK, c-fos, and c-Jun, three proteins involved in AP1-mediated cell proliferation. Here, JUN is linked to prostate carcinoma.